SelectScience

Drug Discovery & Development Scientists’ Choice Awards winners announced at SLAS2023

Agilent Technologies, Sartorius, and Corning Life Sciences among those recognized

28 Feb 2023


The Seahorse XF Pro Analyzer with the 2023 Scientists' Choice Awards winner badge
The Seahorse XF Pro Analyzer from Agilent Technologies was voted Best New Drug Discovery & Development Product of 2022

The world’s most innovative and effective technologies advancing drug discovery and development have been recognized during a special ceremony at the 2023 SLAS International Conference and Exhibition. Winners of the 2023 Scientists’ Choice Awards® were announced by SelectScience® Vice President, Jay Leech, and Executive Editor, Dr. Lois Manton-O'Byrne.

Now in their 16th year, the awards are unique in the industry as they are chosen by scientists. Each year, we invite scientists from around the globe to participate by nominating, reviewing, and voting for the lab products that have had the greatest impact on their work. Read on to reveal your chosen winners.

Best New Drug Discovery & Development Product of 2022

The award for Best New Drug Discovery & Development Product of 2022 goes to the Seahorse XF Pro Analyzer by Agilent Technologies, as voted for by scientists around the world.

Agilent Seahorse XF Pro Analyzers measure the oxygen consumption (OCR) and extracellular acidification rate (ECAR/PER) of live cells in a 96-well format. OCR and ECAR or PER are key indicators of mitochondrial respiration and glycolysis as well as ATP production rate. Together, these measurements provide a systems-level view of cellular metabolic function in cultured cells and ex vivo samples.

Your runners-up are:


Steve Rees OBE, Vice President Discovery Biology, AstraZeneca, joined the Scientists' Choice Awards celebration as a special guest to speak about communication in science

Drug Discovery & Development Webinar of the Year

This year’s Webinar of the Year is awarded to Dr. Archana Thakur, Associate Professor of Medicine, Director of Human Cellular Therapeutics cGMP Core, University of Virginia, School of Medicine, in associate with Agilent Technologies. The webinar, titled ‘Bispecific-antibody-armed, metabolically enhanced headless CAR T cells: Safe and effective serial killers of solid tumors’, available to watch on demand, discusses metabolically enhanced headless CAR T (hCAR T) cells armed with bispecific antibodies (bsAbs) that were created as safe, effective serial killers of tumor targets. 

Drug Discovery & Development Editorial Article of the Year

This winning article is titled ‘Identifying tumor-specific cancer treatments using patient-derived tumor organoids’ and features technology from Corning Life Sciences

In this interview, Dr. Benjamin Hopkins, Assistant Professor at the Icahn School of Medicine at Mount Sinai, New York, discusses how his team is pairing comprehensive genomics with drug screening of high-fidelity patient-derived organoids to help identify effective therapeutic strategies for cancer patients.

Drug Discovery & Development Video of the Year

This year’s winning video is awarded to a presentation titled ‘Single cell antibody discovery using 'Islands of automation', this video discusses work to automate single-cell processes used for biologics discovery specifically antibody discovery. 


From top to bottom: Michelle Kleist, Marketing Manager, and Kellie Chadwick, Agilent Technologies, Chris Ward, Marketing Communications for Cell Therapy & Bioprocess, Corning Life Sciences, Andrea Brütsch, Global Product Manager, METTLER-TOLEDO, and Hannah Puzas, Sartorius Group. 

Drug Discovery & Development Application eBook of the Year 

The Drug Discovery & Development Application eBook of the Year Award goes to Sartorius Group for ‘Achieve lab weighing compliance with ease’. This application compendium illustrates the importance of weighing compliance in the regulated lab and provides you with the tools to achieve greater lab efficiency.

Drug Discovery & Development Email of the Year

The winner in the Email of the Year category goes to ‘Be compliant with European Pharmacopoeia General Chapter 2.1.7’, from Mettler-Toledo GmbH. The winning email featured a downloadable white paper explaining the scope and requirements of Ph. Eur. Chapter 2.1.7 and what you need to do to ensure compliance.

Do you use any of these lab products? Share your opinion today by leaving a lab product review>>


Visit the Scientists’ Choice Awards website for more information